Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus

BACKGROUND/PURPOSE: Dipeptidyl peptidase-4 (DPP-4) inhibitors are the most popular oral antidiabetic drugs (OADs) in recent 20 years because of the low risk of hypoglycemia, intermediate efficacy to lower glycated hemoglobin (△HbA1c): 0.5–0.9%, neutral effect on body weight change, convenience for u...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Hsin, Huang, Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935284/
https://www.ncbi.nlm.nih.gov/pubmed/31920352
http://dx.doi.org/10.2147/DMSO.S220180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935284/
https://www.ncbi.nlm.nih.gov/pubmed/31920352
http://dx.doi.org/10.2147/DMSO.S220180

Ejemplares similares